FDA Halt on Genetic Engineering Trials Abroad
The US Food and Drug Administration (FDA) has halted new clinical trials that involve exporting American cells to foreign labs in hostile countries for genetic engineering. This move comes after the Biden Administration’s policies were criticized as having created a “dangerous blind spot” in research security. NIH Director Dr. Jay Bhattacharya stated that the agency … Read more